Lindau Stacy Tessler, Drum Melinda L, Gaumer Elyzabeth, Surawska Hanna, Jordan Jeanne A
University of Chicago Department of Obstetrics and Gynecology, the University of Chicago Cancer Research Center, Chicago, IL 60637, USA.
Obstet Gynecol. 2008 Nov;112(5):979-89. doi: 10.1097/AOG.0b013e31818b0df2.
To estimate the prevalence, genotypes, and individual-level correlates of high-risk human papillomavirus (HPV) among women aged 57-85.
Community-residing women (N=1,550), aged 57-85, were drawn from a nationally representative probability sample. In-home interviews and biomeasures, including a self-collected vaginal specimen, were obtained between 2005 and 2006. Specimens were analyzed for high-risk HPV DNA using Hybrid Capture 2; of 1,028 specimens provided, 1,010 were adequate for analysis. All samples testing positive were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization.
The overall population-based weighted estimate of high-risk HPV prevalence by Hybrid Capture 2 (Digene Corp.) was 6.0% (95% confidence interval 4.5- 7.9). Current marital and smoking status, frequency of sexual activity, history of cancer, and hysterectomy were associated with high-risk HPV positivity. Among high-risk HPV-positive women, 63% had multiple type infections. Human papillomavirus-16 or -18 was present in 17.4% of all high-risk HPV-positive women. The most common high-risk genotypes among high-risk HPV-positive women were HPV-61 (19.1%), -31 (13.1%), -52 (12.9%), -58 (12.5%), -83 (12.3%), -66 (12.0%), -51 (11.7%), -45 (11.2%), -56 (10.3%), -53 (10.2%), -16 (9.7%), and -62 (9.2%). Being married and having an intact uterus were independently associated with lower prevalence of high-risk HPV. Among unmarried women, current sexual activity and smoking were independently and positively associated with high-risk HPV infection.
In this nationally representative population, nearly 1 in 16 women aged 57-85 was found to have high-risk HPV, and prevalence was stable across older age groups.
II.
评估57至85岁女性中高危型人乳头瘤病毒(HPV)的患病率、基因型及个体层面的相关因素。
从全国代表性概率样本中抽取1550名年龄在57至85岁的社区居住女性。在2005年至2006年期间进行了入户访谈和生物测量,包括自行采集的阴道标本。使用杂交捕获2法对标本进行高危型HPV DNA分析;在提供的1028份标本中,1010份标本适合分析。所有检测呈阳性的样本通过L1共识聚合酶链反应进行HPV DNA分析,随后进行型特异性杂交。
采用杂交捕获2法(Digene公司)基于总体人群的高危型HPV患病率加权估计为6.0%(95%置信区间4.5 - 7.9)。当前婚姻和吸烟状况、性活动频率、癌症病史及子宫切除术与高危型HPV阳性相关。在高危型HPV阳性女性中,63%有多种类型感染。17.4%的高危型HPV阳性女性感染了人乳头瘤病毒16型或18型。高危型HPV阳性女性中最常见的高危基因型为HPV - 61(19.1%)、- 31(13.1%)、- 52(12.9%)、- 58(12.5%)、- 83(12.3%)、- 66(12.0%)、- 51(11.7%)、- 45(11.2%)、- 56(10.3%)、- 53(10.2%)、- 16(9.7%)和- 62(9.2%)。已婚且子宫完整与高危型HPV患病率较低独立相关。在未婚女性中,当前性活动和吸烟与高危型HPV感染独立且呈正相关。
在这个全国代表性人群中,发现57至85岁女性中近十六分之一感染高危型HPV,且患病率在各老年组中稳定。
II级。